Promoted Content Promoted Content


Find Drugs for Trauma (Emergency, Injury, Surgery) in Preclinical Development in UNITED STATES


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): TT-20

            Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: TT-20

            Highest Development Status: Preclinical Product Type: Small molecule

            Partner/Sponsor/Collaborator: Xontogeny, LLC

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Financing May 12, 2021


            Tellus’s lead candidate, TT-20, is derived from a class of molecules found in breast milk, which promote oligodendrocyte differentiation in postnatal neural stem cell populations.